Anti-CHK1 monoclonal antibody

Pre-made anti-CHK1 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to CHK1/CHEK1 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-T62449-Ab-1/ GM-Tg-hg-T62449-Ab-2Anti-Human CHK1/CHEK1 monoclonal antibodyHuman
GM-Tg-rg-T62449-Ab-1/ GM-Tg-rg-T62449-Ab-2Anti-Rat CHK1/CHEK1 monoclonal antibodyRat
GM-Tg-mg-T62449-Ab-1/ GM-Tg-mg-T62449-Ab-2Anti-Mouse CHK1/CHEK1 monoclonal antibodyMouse
GM-Tg-cynog-T62449-Ab-1/ GM-Tg-cynog-T62449-Ab-2Anti-Cynomolgus/ Rhesus macaque CHK1/CHEK1 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-T62449-Ab-1/ GM-Tg-felg-T62449-Ab-2Anti-Feline CHK1/CHEK1 monoclonal antibodyFeline
GM-Tg-cang-T62449-Ab-1/ GM-Tg-cang-T62449-Ab-2Anti-Canine CHK1/CHEK1 monoclonal antibodyCanine
GM-Tg-bovg-T62449-Ab-1/ GM-Tg-bovg-T62449-Ab-2Anti-Bovine CHK1/CHEK1 monoclonal antibodyBovine
GM-Tg-equg-T62449-Ab-1/ GM-Tg-equg-T62449-Ab-2Anti-Equine CHK1/CHEK1 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-T62449-Ab-1/ GM-Tg-hg-T62449-Ab-2; GM-Tg-rg-T62449-Ab-1/ GM-Tg-rg-T62449-Ab-2;
GM-Tg-mg-T62449-Ab-1/ GM-Tg-mg-T62449-Ab-2; GM-Tg-cynog-T62449-Ab-1/ GM-Tg-cynog-T62449-Ab-2;
GM-Tg-felg-T62449-Ab-1/ GM-Tg-felg-T62449-Ab-2; GM-Tg-cang-T62449-Ab-1/ GM-Tg-cang-T62449-Ab-2;
GM-Tg-bovg-T62449-Ab-1/ GM-Tg-bovg-T62449-Ab-2; GM-Tg-equg-T62449-Ab-1/ GM-Tg-equg-T62449-Ab-2
Products NameAnti-CHK1/CHEK1 monoclonal antibody
Formatmab
Target NameCHK1
Protein Sub-locationIntrocelluar Protein
Category of antibodyTherapeutics Target antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-CHK1 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-T62449-Ag-1Recombinant multi-species CHK1/ CHEK1 protein
    ORF Viral VectorpGMLP003747human CHEK1 Lentivirus plasmid
    ORF Viral VectorvGMLP003747human CHEK1 Lentivirus particle


    Target information

    Target IDGM-T62449
    Target NameCHK1
    Gene ID1111,12649,140583,713358,609767,101083365,513678,100064353
    Gene Symbol and SynonymsCHEK1,CHK1,rad27
    Uniprot AccessionO14757,Q91ZN7
    Uniprot Entry NameCHK1_HUMAN,CHK1_RAT
    Protein Sub-locationIntrocelluar Protein
    CategoryTherapeutics Target
    DiseaseCancer
    Gene EnsemblENSG00000149554
    Target ClassificationKinase, Tumor-associated antigen (TAA)

    The target: CHK1, gene name: CHEK1, also named as CHK1. The protein encoded by this gene belongs to the Ser/Thr protein kinase family. It is required for checkpoint mediated cell cycle arrest in response to DNA damage or the presence of unreplicated DNA. This protein acts to integrate signals from A™ and ATR, two cell cycle proteins involved in DNA damage responses, that also associate with chromatin in meiotic prophase I. Phosphorylation of CDC25A protein phosphatase by this protein is required for cells to delay cell cycle progression in response to double-strand DNA breaks. Several alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Oct 2011].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.